Hyperbaric oxygen therapy reduces the risk of QTc interval prolongation in patients with diabetes and hard-to-heal foot ulcers.
(2015) In Journal of Diabetes and its Complications 29(8). p.1198-1202- Abstract
- Heart rate corrected QT (QTc) interval prolongation is a risk factor associated with increased mortality. Hyperbaric oxygen therapy (HBO) has previously been shown to have acute beneficial effects on QTc dispersion. The aim of this study was to evaluate long-term effects of HBO on QTc time in diabetic patients with hard-to-heal foot ulcers.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8043670
- author
- Fagher, Katarina LU ; Katzman, Per LU and Löndahl, Magnus LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Diabetes and its Complications
- volume
- 29
- issue
- 8
- pages
- 1198 - 1202
- publisher
- Elsevier
- external identifiers
-
- pmid:26321368
- wos:000366884900038
- scopus:84947615345
- pmid:26321368
- ISSN
- 1873-460X
- DOI
- 10.1016/j.jdiacomp.2015.07.023
- language
- English
- LU publication?
- yes
- id
- 632f635d-93cd-4405-a10d-2cf2a397940f (old id 8043670)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26321368?dopt=Abstract
- date added to LUP
- 2016-04-01 10:24:15
- date last changed
- 2024-10-07 04:13:33
@article{632f635d-93cd-4405-a10d-2cf2a397940f, abstract = {{Heart rate corrected QT (QTc) interval prolongation is a risk factor associated with increased mortality. Hyperbaric oxygen therapy (HBO) has previously been shown to have acute beneficial effects on QTc dispersion. The aim of this study was to evaluate long-term effects of HBO on QTc time in diabetic patients with hard-to-heal foot ulcers.}}, author = {{Fagher, Katarina and Katzman, Per and Löndahl, Magnus}}, issn = {{1873-460X}}, language = {{eng}}, number = {{8}}, pages = {{1198--1202}}, publisher = {{Elsevier}}, series = {{Journal of Diabetes and its Complications}}, title = {{Hyperbaric oxygen therapy reduces the risk of QTc interval prolongation in patients with diabetes and hard-to-heal foot ulcers.}}, url = {{http://dx.doi.org/10.1016/j.jdiacomp.2015.07.023}}, doi = {{10.1016/j.jdiacomp.2015.07.023}}, volume = {{29}}, year = {{2015}}, }